A third COVID-19 vaccine hits the U.S. market

To listen to all PwC Next in Health podcasts, click here. Subscribe and listen to all episodes at your convenience via any device at Apple Podcasts, Spotify and Stitcher.


Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on the latest vaccine authorized by the Food and Drug Administration (FDA) for emergency use, including:

  • Vaccine clinical trials and the efficacy rate on COVID-19 related infections
  • Expected uptick in the overall vaccine supply
  • Existing COVID-19 vaccines’ effectiveness on COVID-19 variants
  • FDA’s updated guidance to address vaccines and emerging COVID-19 variants

Topics: Vaccines, variants, supply chain

Contact us

Benjamin Isgur

Benjamin Isgur

Health Research Institute Leader, PwC US

Trine K. Tsouderos

Trine K. Tsouderos

HRI Regulatory Center Leader, PwC US

Tel: +1 (312) 241 3824

Follow us